MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-TS-09-0020079
Saptagir Laboratories Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹60.25 Cr
▲ 8% YoY
Net profit · FY 2025
₹6.03 Cr
Net margin 10%
EBITDA · FY 2025
₹9.64 Cr
EBITDA margin 16%
Authorised capital
₹17 Cr
Registered with MCA
Paid-up capital
₹15.78 Cr
Issued & subscribed
Satisfied charges
₹16.9 Cr
No open charges
Company age
19 yrs
Est. 2007
Employees · EPFO
58
Provident fund records
About Saptagir Laboratories Private Limited
Data last updated:
Saptagir Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Saptagir Life Sciences Private Limited. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 18 July 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2007PTC054831. Its GSTIN is 36AAGCA4302C1ZC (Telangana).
The company has an authorised share capital of ₹17 Cr and a paid-up capital of ₹15.78 Cr. It was formerly known as Astrica Laboratories Private Limited. It is led by directors including Silpa Reddy Reganti (Managing Director) and Ranga Reddy Mallepalli.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D.No – 1 – 72/19 To 49 Plot No. 6D 6th Floor Vaishnavi'S Cynosure Gachibowli, Hyderabad, Telangana, India – 500032.
As per the financials filed for FY 2025, the company reported a revenue of ₹60.25 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹6.03 Cr (net margin 10%) and EBITDA of ₹9.64 Cr (EBITDA margin 16%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 54% over five years.
The company has about 58 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹16.9 Cr on record. Court records list 6 cases involving the company, including 6 filed by the company; 6 cases are pending. The company has 12 deals on record (8 secondary share transfers, 4 funding rounds), with disclosed funding of ₹15.77 Cr; the latest was in May 2019. Its 8 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Srikem Laboratories Private Limited with revenue of ₹64.78 Cr.
Saptagir Laboratories Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0020079). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website saptagirlabs.com.
Company details
CIN U24232TG2007PTC054831
Registration Number 054831
Incorporation Date 18 July 2007
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Parent Company Saptagir Life Sciences Private Limited
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-09-0020079
CIN history
Saptagir Laboratories has one previous CIN (Corporate Identification Number): U24232AP2007PTC054831. The current CIN is U24232TG2007PTC054831, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2007PTC054831 | Current |
| U24232AP2007PTC054831 | Previous |
Key People
Silpa Reddy Reganti Managing Director Ranga Reddy Mallepalli Director Narayana Rao Nambu Director Recognitions & Rankings of Saptagir Laboratories
Contact details
Saptagir Laboratories Private Limited's registered office is in Hyderabad, Telangana. Its website is saptagirlabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressD.No – 1 – 72/19 To 49 Plot No. 6D 6th Floor Vaishnavi'S Cynosure Gachibowli, Hyderabad, Telangana, India – 500032
- IndustryPharma, API Manufacturers
To see the full contact details of Saptagir Laboratories Private Limited, buy the company report.
Comprehensive company report
Saptagir Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Saptagir Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Saptagir Laboratories Private Limited, buy the company report.
Financials of Saptagir Laboratories Private Limited
FY 2025 filings availableSaptagir Laboratories Private Limited reported revenue of ₹60.25 Cr (up 8% YoY) for FY 2025.
Revenue · FY 2025
₹60.25 Cr ▲ 8%
Net profit · FY 2025
₹6.03 Cr margin 10%
EBITDA · FY 2025
₹9.64 Cr margin 16%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 8%
3 years · compounded
▼ 1%
5 years · compounded
▲ 54%
EBITDA CAGR growth
1 year
▼ 6%
3 years · compounded
▲ 49%
5 years · compounded
▲ 25%
Revenue has grown at a compounded annual rate (CAGR) of 54% over five years, including 8% growth in the latest year. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.64 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.03 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16% | ||||
| Net Profit Margin | 10% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Saptagir Laboratories Private Limited, buy the company report.
Board of directors of Saptagir Laboratories Private Limited
Saptagir Laboratories has 3 current directors and 19 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Silpa Reddy Reganti | Managing Director | 17 Mar 2020 | 6 Years 7 Months | Current |
| Ranga Reddy Mallepalli | Director | 24 Jun 2019 | 7 Years 4 Months | Current |
| Narayana Rao Nambu Also directs: Deneb Enterprises Private Limited, Ur Properties Private Limited, Deneb Enterprises Private Limited and 3 more | Director | 10 Dec 2019 | 6 Years 11 Months | Current |
Peer comparison
Saptagir Laboratories Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Srikem Laboratories Private Limited | ₹64.78 Cr (FY 2024) | 20.0% | Mumbai, Maharashtra, India | |||
| Chandra Life Sciences Private Limited | ₹63.01 Cr (FY 2024) | 4.0% | Hyderabad, Telangana, India | |||
| Androst Biotech India Private Limited | ₹61.85 Cr (FY 2025) | -12.0% | Anand, Gujarat, India | |||
| Saptagir Laboratories Private Limitedthis company | ₹60.25 Cr (FY 2025) | ₹6.03 Cr | 10% | 8.0% | Hyderabad, Telangana, India | |
| Cadchem Laboratories Limited | ₹59.73 Cr (FY 2024) | -13.0% | Chandigarh, India | |||
| Macsen Labs Limited | ₹59.7 Cr (FY 2025) | -9.0% | Udaipur, Rajasthan, India | |||
| Bhasya International Private Limited | ₹59.51 Cr (FY 2024) | 124.0% | Hyderabad, Telangana, India | |||
| Vaasavaa Pharmaceuticals Private Limited | ₹59.28 Cr (FY 2025) | 16.0% | Solapur, Maharashtra, India | |||
| Venus Chemicals and Drugs Private Limited | ₹59.13 Cr (FY 2025) | 66.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Saptagir Laboratories Private Limited, buy the company report.
Auditor
Saptagir Laboratories Private Limited is audited by K VENKATESWARA RAO & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K VENKATESWARA RAO & ASSOCIATES | FY 2023 | 006374S |
Shareholding
The shareholding of Saptagir Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Saptagir Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹16.9 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Jul 2015 | 10627739 | Others | ₹16.9 Cr | Satisfied |
To see the full charge records of Saptagir Laboratories Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Saptagir Laboratories Private Limited has 12 deals on record (8 secondary share transfers, 4 funding rounds), with disclosed funding of ₹15.77 Cr; the latest was in May 2019.
Total deals
12
Secondary share transfers
8
Funding rounds
4
Disclosed funding
₹15.77 Cr
Deals on record (5 of 12)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2019 | Secondary share transfer | Undisclosed | Buyer: Saptagir Life Sciences Private Limited , Saptagir Life Sciences Private Limited & Vijaya Kumar Jetty Seller: 4 individuals |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: Saaketh Infracon India Private Limited , 2 individuals Seller: Saaketh Iron Industries Private Limited , 3 individuals |
| Aug 2017 | Funding round | ₹2.2 Cr | Investors: 4 individuals |
| Jul 2016 | Funding round | ₹3.7 Cr | Investors: Saaketh Infracon India Private Limited , Saaketh Iron Industries Private Limited , 2 individuals |
| Nov 2015 | Funding round | ₹7.65 Cr | Investors: 4 individuals |
To see the full deal history of Saptagir Laboratories Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Saptagir Laboratories Private Limited has 6 court cases on record: 6 filed by Saptagir Laboratories. All cases are pending.
Total cases
6
Filed by the company
6
Pending
6
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 0 | 6 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad Central, Telangana | Cheque dishonour complaint | Filed by the company against M/S. Sri Balaji Enterprises Rep. by Dhuda Ram | Pending |
| District court, Hyderabad Central, Telangana | Cheque dishonour complaint | Filed by the company against M/S. Avents Pharmaceuticals, Rep. by Srikanth | Pending |
| District court, Hyderabad Central, Telangana | Cheque dishonour complaint | Filed by the company against M/S. Agarwal Enterprises, Rep. by Anil Agarwal | Pending |
| District court, Hyderabad Central, Telangana | Cheque dishonour complaint | Filed by the company against M/S. Sri Balaji Enterprises, Rep. by D. Ram Prajapati | Pending |
| District court, Hyderabad Central, Telangana | Cheque dishonour complaint | Filed by the company against M/S. Sri Balaji Enterprises | Pending |
To see the full case history of Saptagir Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Saptagir Laboratories Private Limited was last rated by Care on 03 Nov 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 03 Nov 2021 |
To see the full credit ratings and regulatory alerts of Saptagir Laboratories Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Saptagir Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Saptagir Laboratories has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCA4302C1ZC | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Saptagir Laboratories Private Limited, buy the company report.
Recent activity
Saptagir Laboratories Private Limited has 21 board changes on record since 2013: 3 appointments and 18 cessations. The latest: Silpa Reddy Reganti ceased to be Additional Director on 30 Dec 2020.
AGM
Saptagir Laboratories Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Saptagir Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Silpa Reddy Reganti ceased to be Additional Director.
Charges
A charge registered on 04 Jul 2015 via Charge ID 10627739 with Others was fully satisfied on 14 May 2020.
Appointed
Silpa Reddy Reganti was appointed as Managing Director.
Appointed
Narayana Rao Nambu was appointed as Director.
Ceased
Chandan Kumar ceased to be Nominee Director.
Ceased
Narayana Rao Nambu ceased to be Nominee Director.
Ceased
Ranga Reddy Mallepalli ceased to be Additional Director.
Appointed
Ranga Reddy Mallepalli was appointed as Director.
Ceased
Vijaya Kumar Jetty ceased to be Nominee Director.
Ceased
Dabbara Gopal Krishna ceased to be Director.
15 earlier events are in the company report.
Frequently asked questions
Saptagir Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 18 July 2007 (19+ years old) and is registered under CIN U24232TG2007PTC054831.
Saptagir Laboratories has 3 current directors:
- Silpa Reddy Reganti - Managing Director
- Ranga Reddy Mallepalli - Director
- Narayana Rao Nambu - Director
The latest financial statements of Saptagir Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Saptagir Laboratories is 36AAGCA4302C1ZC, registered in Telangana.
The CIN (Corporate Identification Number) of Saptagir Laboratories is U24232TG2007PTC054831. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Saptagir Laboratories has 6 court cases on record: 6 filed by the company. 6 are pending.
Saptagir Laboratories was incorporated on 18 July 2007, making it 19+ years old. It is registered with the Registrar of Companies, Hyderabad.
Saptagir Laboratories has 12 deals on record (8 secondary share transfers, 4 funding rounds), with disclosed funding of ₹15.77 Cr; the latest was in May 2019.
The peers of Saptagir Laboratories by revenue are Srikem Laboratories Private Limited, Chandra Life Sciences Private Limited, Androst Biotech India Private Limited, Cadchem Laboratories Limited, Macsen Labs Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Silpa Reddy Reganti ceased to be Additional Director on 30 Dec 2020. Silpa Reddy Reganti was appointed as Managing Director on 17 Mar 2020. Narayana Rao Nambu was appointed as Director on 10 Dec 2019. Saptagir Laboratories has 21 board changes on record in total.
Yes, Saptagir Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-09-0020079).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages